Bristol-Myers Squibb (BMY) Stock Forecast & Price Target
Score
Bristol-Myers Squibb Company price target
| BMY | |
|---|---|
| Low | $41.00 |
| Average | $66.08 |
| High | $78.00 |
| Upside vs current price | +4.2% |
The average target of $66.08 is +4.2% versus the current BMY price of $63.43.
Bristol-Myers Squibb Company analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 4 |
| Buy | 6 |
| Hold | 17 |
| Sell | 1 |
| Strong sell | 0 |
| Consensus | Hold |
28 analysts cover BMY.
Bristol-Myers Squibb Company EPS and revenue estimates
The estimate table for the Bristol-Myers Squibb Company keeps 2026 EPS $6.44, 2027 EPS $6.66, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $6.44 | $50.11B |
| 2027 | $6.66 | $48.74B |
Is Bristol-Myers Squibb Company a buy or sell?
Of the 28 analysts covering Bristol-Myers Squibb Company, 10 rate it a buy (4 strong buy and 6 buy), 17 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).
The BMY consensus label is Hold, beside 10 buy-side ratings and 1 sell-side ratings.
The average target of $66.08 implies +4.2% versus the current price of $63.43.
the Bristol-Myers Squibb Company closes with 10 buy-side ratings and 1 on the sell side. The headcount is Hold.
Reading the Bristol-Myers Squibb Company forecast
Analysts are far apart on BMY. The published low is $41.00, the average is $66.08, and the high is $78.00.
From today's $63.43 print, the BMY average target is +4.2% away.
Buy and the rest of the scale both have a real share of BMY: 10 of 28 analysts are on the buy side, 17 are at hold, and 1 is on the sell side, and the published consensus is Hold.
BMY has both upgrades (1) and downgrades (1) in the recent window.
BMY targets have eased: $62.83 in the last month against $67.00 over the last quarter.
Coverage of BMY is broad at 28 analysts, and the average is a crowd rather than a single desk.
Bristol-Myers Squibb Company forecast questions
What is the BMY price target?
The published range for BMY is $41.00 to $78.00, with an average of $66.08. That average is +4.2% versus the current price of $63.43.
Is Bristol-Myers Squibb Company a buy or sell?
Of the 28 analysts covering Bristol-Myers Squibb Company, 10 rate it a buy, 17 rate it a hold, and 1 rates it a sell. The consensus is Hold, which for BMY is 10 on the buy side, 17 at hold, and 1 on the sell side.
What is the EPS estimate for Bristol-Myers Squibb Company?
Analyst EPS estimates for Bristol-Myers Squibb Company: 2026 $6.44, 2027 $6.66.
What is the revenue estimate for Bristol-Myers Squibb Company?
Analyst revenue estimates for Bristol-Myers Squibb Company: 2026 $50.11B, 2027 $48.74B.
How many analysts cover BMY?
28 analysts cover BMY. Their consensus on BMY is Hold, across those 28.